[Recent observations on the drug treatment of renal lithiasis. Physico-chemical and biological bases].
D000284:Administration, Oral; D000493:Allopurinol / Q000627:therapeutic use; D000643:Ammonium Chloride / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D002951:Citrates / Q000627:therapeutic use; D004035:Diet Therapy; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D005665:Furosemide / Q000627:therapeutic use; D006801:Humans; D007263:Infusions, Parenteral; D007474:Ion Exchange / Q000627:therapeutic use; D007669:Kidney Calculi / Q000188:drug therapy*; D008297:Male; D011189:Potassium Chloride / Q000627:therapeutic use; D011773:Pyruvates / Q000627:therapeutic use; D007507:Therapeutic Irrigation / Q000009:adverse effects; D014556:Urine / Q000032:analysis; D014815:Vitamins / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D002951:Citrates; D005343:Fibrinolytic Agents; D011773:Pyruvates; D014815:Vitamins; D000643:Ammonium Chloride; D000493:Allopurinol; D011189:Potassium Chloride; D005665:Furosemide
Neue Erkenntnisse in der medikamentösen Therapie der Nierensteinerkrankung. Physikalisch-chemische und biologische Grundlagen.